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	 Condensation	 of	 L‐arginine	 with	 4‐hydroxy‐3‐methoxy	 benzaldehyde	 (vanillin)	 yielded	 a
novel	Schiff	base	derivative	of	arginine	in	good	yield.	This	new	Schiff	base	was	characterized
by	elemental	analysis,	IR	and	1H	NMR	spectroscopy.	The	toxicity	of	the	compound	was	also
assayed	via	the	determination	of	their	LD50	value	by	using	Dixon	method.	Studied	compound
was	found	to	have	an	LD50	of	718.6	mg/kg	of	body	weight.	
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1.	Introduction	
	
L‐Arginine	 is	 a	 basic	 natural	 amino	 acid.	 It	 plays	 an	
important	 role	 in	 cell	 division,	 the	 healing	 of	 wounds,	
removing	ammonia	 from	the	body,	 immune	 function,	and	 the	
release	 of	 hormones	 [1‐3].	 It	 has	 high	 important	 in	 many	
diseases,	 low	 dose	 IV	 arginine	 has	 been	 shown	 to	 improve	
insulin	 sensitivity	 in	 obese,	 type	 2	 diabetic,	 and	 healthy	
subjects	 [4].	 Arginine	may	 also	 counteract	 lipid	 peroxidation	
and	thereby	reduce	microangiopathic	long‐term	complications	
of	diabetes	mellitus	[5].	L‐Arginine	has	been	purported	to	have	
ergogenic	 potential	 [6].	 L‐Arginine	 stimulates	 the	 release	 of	
growth	 hormone	 [7],	 as	 well	 as	 the	 release	 of	 pancreatic	
insulin	 and	 glucagon	 and	 pituitary	 prolactin	 [8].	 The	
antioxidant	property	of	L‐arginine	has	been	well	documented	
in	several	reports	[5,8].	An	interesting	article	by	Grasemann	et	
al.	 2006	 [9],	 has	 demonstrated	 an	 acute	 and	 transient	
improvement	of	pulmonary	function	in	cystic	fibrosis	patients	
by	a	single	inhalation	of	L‐arginine	[10].		
Sarı	 and	 Gurkan	 synthesized	 a	 new	 Schiff	 bases	 derived	
from	thiophene‐2‐carbaldehyde	with	some	amino	acids	as	DL‐
alanine,	 DL‐valine	 and	 DL‐phenylalanine,	 with	 a	 new	 alter‐
native	 method	 [11].	 Vanillin	 is	 used	 as	 a	 flavoring	 aromatic	
compound	in	foods	and	fragrance	industries.		
Synthetic	 vanillin	 is	 used	 as	 an	 intermediate	 in	 the	
chemical	 and	 pharmaceutical	 industries	 for	 the	 synthesis	 of	
herbicides	 and	 drugs	 [12].	 Recent	 reports	 have	 shown	 that	
vanillin	 can	 act	 as	 an	 antioxidant	 improving	 the	 keeping	
quality	 of	 precooked	 dried	 cereal	 flakes	 [13]	 and	 afforded	
significant	 protection	 against	 protein	 oxidation	 and	 lipid	
peroxidation	in	rat	liver	mitochondria	[14].	The	aim	of	present	
work	was	synthesized	novel	arginin	derivative	byreaction	of	L‐
arginine	with	bioactive	materials	vanillin.	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
Infrared	 spectra	 (IR)	 were	 recorded	 as	 KBr	 discs	 in	 the	
range	 of	 4000‐400	 cm‐1	 using	 Shimadzu	 FT‐IR	 spectrophoto‐
meter	 in	 the	 Department	 of	 Chemistry,	 College	 of	 Education	
for	Pure	Sciences,	University	of	Basrah,	 Iraq.	 1H	NMR	spectra	
were	measured	on	a	Bruker	at	600	MHz,	with	TMS	as	internal	
reference	at	Konstanz	University,	Germany.	Microanalysis	 for	
carbon,	hydrogen	and	nitrogen	were	carried	out	by	a	Perkin‐
Elmer	240B	Elemental	Analyzer.	Melting	points	were	measu‐
red	 by	 a	 Philip	 Harris	 melting	 point	 apparatus	 and	
uncorrected.	
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Table	1.	Dixon	values.	
Second	part	
of	serial	
+	K	represented	serial	tests	as	follows	 	
O	 OO OOO OOOO
XOOO	 ‐0.157	 ‐0.154	 ‐0.154	 ‐0.154	 OXXX	
XOOX	 0.878	 ‐0.861	 ‐0.860	 ‐0.860	 OXXO	
XOXO	 0.701	 0.737 0.741 0.741 OXOX
XOXX	 0.084	 0.169 0.181 0.186 OXOO
XXOO	 0.305	 0.372 0.380 0.381 OOXX
XXOX	 ‐0.305	 0.169 ‐0.144 ‐0.142 OOXO
XXXO	 1.288	 1.500 1.544 1.549 OOOX
XXXX	 0.555	 0.896 0.985 1.007 OOOO
	 X	 XX XXX XXXX Second	part
of	serial	‐	K	represented	serial	results	as	follows
		
	
Scheme	1	
 
 
2.2.	Acute	toxicity	(LD50)	
	
All	experiments	were	performed	on	10‐14	weeks	old	male	
and	female	ratus‐ratus/rats	weighing	200‐250	g	at	the	time	of	
treatment	 by	 using	 up‐and‐down	 method	 [15].	 Male	 and	
female	rats	were	injected	intraperitonially	with	different	doses	
of	 the	arginin	derivative	after	conducting	series	of	 test	 levels.	
With	 equal	 spacing	 between	 doses,	 a	 series	 of	 trails	 were	
carried	 out	 using	 this	 method:	 increased	 dose	 following	 a	
negative	 response	 and	 decreased	 dose	 following	 a	 positive	
response.	 Testing	 continued	 until	 chosen	 "nominal"	 sample	
size	 was	 reached.	 LD50	 were	 determined	 after	 reading	 final	
result	(response‐dead	(X)	or	non‐response	alive	(O),	 then	the	
following	equation	was	applied	
	
 LD50	=	XF	+	K×d	 	 	 	 	 (1)	
 
where,	LD50:		Median	lethal	dose;	XF:	Last	dose	administered;	K	
=	 Value	 from	 Table	 1;	 D	 =	 Difference	 between	 dose	 levels	
(Table	1)	[15].	
	
2.3.	Synthesis	
	
2.3.1.	Synthesis	of	5‐carbamimidamido‐2‐[(4‐hydroxy‐3‐
methoxybenzylidene)amino]pentanoic	acid	
	
A	solution	of	L‐arginin	(1.722	g,	10	mmole)	in	ethanol	(15	
mL)	 was	 added	 to	 a	 solution	 of	 4‐hydroxy‐3‐methoxy	
benzaldehyde	 (vanillin)	 (1.521	 g,	 10	 mmole)	 in	 ethanol	 (15	
mL).	The	mixture	was	 refluxed	 for	4	hours	with	 stirring.	The	
resulting	was	 a	 yellow	 solution	 allowed	 to	 cool	 and	 dried	 at	
room	 temperature,	 then	 re‐crystallization	 to	 the	 precipitate	
with	 ethanol,	 brown	 solid	 was	 obtained	 by	 evaporation	 of	
ethanol	during	24	hours,	Scheme	1.	Yield:	86%.	M.p.:	116‐118	
°C.	 FT‐IR	 (KBr,	 ,	 cm‐1):	 3107‐3338	 (OH,	 NH),	 3060	 (C‐H,	
Aromatic),	 2960,	 2933	 (C‐H,	 Aliphatic),	 1666	 (C=N),	 1639	
(C=C),	 1573,	 1398	 (COOH).	 1H	 NMR	 (600	 MHz,	 DMSO‐d6,	 δ,	
ppm):	 11.75	 (s,	 1H,	 COOH),	 8.89	 (s,	 1H,	 Ar‐OH),	 8.43	 (s,	 1H,	
CH=N),	7.37‐6.16	(m,	3H,	Ar‐H),	3.89‐3.73	(m,	4H,	NH	+	NH2	+	
NH),	 3.07	 (s,	 3H,	OCH3),	 2.95	 (t,	 2H,	 CH2‐N),	 2.44	 (t,	 1H,	 CH‐
COOH),	1.64‐1.44	(m,	4H,	2CH2).	Anal.	calcd.	for	C14H20N4O4:	C,	
54.54;	H,	6.54;	N,	18.17.	Found:	C,	54.68;	H,	7.02	;	N,	18.41%.	
	
3.	Results	and	discussion		
	
3.1.	Chemistry	
	
Isolated	yield,	melting	point,	color	and	spectral	data	IR	and	
1H	NMR	of	synthesized	compound	was	reported.	The	present	
work	 describes	 the	 synthesis	 of	 new	 Schiff	 base	 compound	
derived	 from	 L‐arginine	 and	 vanillin	 to	 produce	 bioactive	
Schiff	base,	 thus,	 the	reaction	of	amino	acid	(L‐arginine)	with	
4‐hydroxy‐3‐methoxy	 benzaldehyde	 (vanillin)	 at	 1:1	 mole	
ratio	afforded,	after	purification	the	new	Schiff	base	derivative	
compound	in	good	yield.	IR	spectra	for	synthesized	compound	
displayed	 common	 features	 in	 certain	 regions	 and	
characteristic	bands	in	the	finger	print	and	other	regions.	The	
IR	spectra	of	new	prepared	compound	show	strong	and	broad	
bands	 in	 the	 range	 3107‐3338	 cm‐1	 due	 to	 OH	 and	 (N‐H)	
symmetrical	 and	 asymmetrical	 stretching	 vibration.	 The	 IR	
spectra	of	synthesized	compound	displays	band	at	1666	cm‐1	is	
due	to	C=N	group	stretching	vibration.	The	band	at	1639	cm‐1	
was	assigned	to	νC=C.	The	bands	at	1573	and	1398	cm‐1	were	
assigned	to	COOH.		
The	1H	NMR	spectra	of	studied	synthesized	compound	was	
recorded	 in	 DMSO‐d6	 solution	 and	 show	 all	 the	 expected	
protons	with	proper	intensity	ratio.	In	1H	NMR	spectrum	of	the	
synthesized	 compound,	 the	 single	 peaks	 attributed	 to	
methylene	 groups	 appeared	 at	 δ	 1.64‐1.44	 ppm	 (2CH2)	 and	
singlet	 peak	 at	 δ	 3.07	 ppm	 due	 to	 methoxy	 (OCH3).	 The	
aromatic	 protons	 of	 compound	 appeared	within	 the	 range	 δ	
7.37‐6.16	ppm.	It	 is	worthy	to	note	that	the	protons	of	Ar‐OH	
resonate	as	a	singlet	at	δ	8.89	ppm.	The	proton	of	azomethine	
(CH=N)	 resonate	 as	 a	 singlet	 at	 δ	 8.43	 ppm,	 single	 peak	
attributed	to	hydroxyl	group	of	carboxylic	appeared	at	δ	11.75	
ppm.	 Four	 groups	 of	 single	 peaks	 given	 by	 (C=NH),	 (C‐NH2)	
and	 (R2‐NH)	 on	 appeared	 at	 δ	 3.89‐3.73	 ppm,	 1H	NMR	 show	
triplet	at	δ	2.95	ppm	attributed	to	CH2‐N	group.		
	
3.2.	Median	lethal	dose	(LD50)	
	
Determination	 of	 the	 50%	 of	 lethal	 dose	 (LD50)	 of	 the	
studied	compound	in‐vivo	was	detected	in	the	rats	by	using	the	
"up‐and‐down"	procedure	described	by	Dixon	method	[15].	In	
the	 experiment,	 we	 using	 10	 animals	 of	 white	 rats	 10‐14	
weeks	 in	age,	Graded	doses	of	 injection	to	each	one	animal,	a	
series	 of	 concentrations	 (500,	 550,	 600,	 650,	 700	 and	 750	
mg/kg	 body	weight)	 in	 0.1	mL	medical	 distilled	 water	 were	
administered	and	chosen	with	equal	spacing	(concentrations)	
between	doses.	Mortality	was	recorded	after	24	hrs	that	each	
one	 animal	 treated	 with	 one	 dose	 and	 after	 24	 hrs	 was	
recorded	 as	 “O”	 if	 the	 animal	 lives	 and	 then	 increased	 the	
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treated	dose.	While	 “X”	 recorded	 for	 the	death	of	animal	and	
then	decreased	the	dose	according	for	the	result	of	the	animal	
the	 code	 which	 formed	 as	 being	 “OOXX”	 and	 according	 for	
Dixon	value	was	get	and	the	LD50	was	determined	according	to	
the	 formula	 employed	 by	 Dixon	method	 [Values:	 LD50	 =	 XF+	
K×d;	LD50	=	700+0.372×50;	LD50	=	718.6	mg/kg	body	weight;	
1/10	 LD50	 =	 71.86	mg/kg	 (1	 kg	 =	 6	 rats)	 (Depending	 on	 the	
weight	 rat	 about	 175	 gram);	 1/10	 LD50=	 11.97	 mg/rat	
(Depending	on	the	weight	rat	175	gram).	
	
4.	Conclusion	
	
In	conclusion,	 the	present	study	reported	the	synthesis	of	
new	 Schiff	 base	 derived	 from	 L‐arginine	 and	 4‐hydroxy‐3‐
methoxy	benzaldehyde	(vanillin)	to	yielded	a	novel	derivative	
of	 arginine	 (5‐carbamimid	 amido‐2‐[(4‐hydroxy‐3‐methoxy	
benzylidene)amino]pentanoic	 acid)	 in	 good	 yield,	 which	
revealed	moderate	in	vivo	toxic	effects	by	LD50	measurement.	
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